Skip to main content
Top
Published in: Medical Oncology 10/2018

Open Access 01-10-2018 | Original Paper

Pre-therapy CT scan showing peritoneal thickening from metastatic renal pelvis carcinoma patients

Authors: Tzu-Yao Liao, Chuang-Chi Liaw, Ke-Hung Tsui, Yu-Hsiang Juan

Published in: Medical Oncology | Issue 10/2018

Login to get access

Abstract

We investigated clinical significance of peritoneal thickening from metastatic renal pelvis based on pretherapy computed tomography (CT) scan findings. The criteria for inclusion were as follows: (1) pathology and CT scan confirmed metastatic renal pelvis carcinoma and (2) peritoneal thickening based on pre-therapy CT scan findings. We investigated the route of spread, gastrointestinal (GI) complications, and response to chemotherapy. A total of 68 cases were enrolled in this study, including seven patients with liver metastases and three with abdominal wall invasion. GI complications included obstruction in ten patients and bleeding in three. Response to chemotherapy demonstrated by reduced peritoneal thickening was noted in 24 patients. In conclusion. peritoneal thickening with clinical suspicion of peritoneal involvement can get indirect evidence from route of spread (liver or abdominal wall), GI complications (obstruction or bleeding) or response to chemotherapy (obvious decrease peritoneal thickening) from metastatic renal pelvis carcinoma patients. Pretherapy CT scan with peritoneal thickening should be alert that tumor has spread to the peritoneum.
Literature
1.
go back to reference Shinagare AB, Fennessy FM, Ramaiya NH, Jagannathan JP, Taplin ME, Van den Abbeele AD. Urothelial cancers of the upper urinary tract: metastatic pattern and its correlation with tumor histopathology and location. J Comput Assist Tomogr. 2011;35:217–22.CrossRefPubMed Shinagare AB, Fennessy FM, Ramaiya NH, Jagannathan JP, Taplin ME, Van den Abbeele AD. Urothelial cancers of the upper urinary tract: metastatic pattern and its correlation with tumor histopathology and location. J Comput Assist Tomogr. 2011;35:217–22.CrossRefPubMed
2.
go back to reference Tan LB, Chang LL, Cheng KI, Huang CH, Kwan AL. Transitional cell carcinomas of the renal pelvis and the ureter: comparative demographic characteristics, pathological grade and stage and 5-year survival in a Taiwanese population. BJU Int. 2009;103:312–6.CrossRefPubMed Tan LB, Chang LL, Cheng KI, Huang CH, Kwan AL. Transitional cell carcinomas of the renal pelvis and the ureter: comparative demographic characteristics, pathological grade and stage and 5-year survival in a Taiwanese population. BJU Int. 2009;103:312–6.CrossRefPubMed
4.
go back to reference Diop AD, Fontarensky M, Montoriol PF, Da Ines D. CT imaging of peritoneal carcinomatosis and its mimics. Diagn Interv Imaging. 2014;95:861–72.CrossRefPubMed Diop AD, Fontarensky M, Montoriol PF, Da Ines D. CT imaging of peritoneal carcinomatosis and its mimics. Diagn Interv Imaging. 2014;95:861–72.CrossRefPubMed
5.
go back to reference Lee O. Patterns of peritoneal spread of tumor in the abdomen and pelvis World. J Radiol. 2013;5:106–12. Lee O. Patterns of peritoneal spread of tumor in the abdomen and pelvis World. J Radiol. 2013;5:106–12.
7.
go back to reference Walkey MM, Friedman AC, Sohotra P, Radecki PD. CT manifestations of peritoneal carcinomatosis. AJR. 1988;150:1035–41.CrossRefPubMed Walkey MM, Friedman AC, Sohotra P, Radecki PD. CT manifestations of peritoneal carcinomatosis. AJR. 1988;150:1035–41.CrossRefPubMed
8.
go back to reference Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumors: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228–47.CrossRefPubMed Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumors: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228–47.CrossRefPubMed
9.
go back to reference Coffin A, Boulay-Coletta I, Sebbag-Sfez D, Zins M. Radioanatomy of the retroperitoneal space. Diagn Interv Imaging. 2015;96:171–86.CrossRefPubMed Coffin A, Boulay-Coletta I, Sebbag-Sfez D, Zins M. Radioanatomy of the retroperitoneal space. Diagn Interv Imaging. 2015;96:171–86.CrossRefPubMed
10.
go back to reference Leake I. Colorectal cancer. Understanding the routes of metastasis in colorectal cancer. Nat Rev Gastroenterol Hepatol. 2014;11(5):270.CrossRefPubMed Leake I. Colorectal cancer. Understanding the routes of metastasis in colorectal cancer. Nat Rev Gastroenterol Hepatol. 2014;11(5):270.CrossRefPubMed
11.
go back to reference Paschos KA, Majeed AW, Bird NC. Natural history of hepatic metastases from colorectal cancer—pathobiological pathways with clinical significance. World J Gastroenterol. 2014;20:3719–37.CrossRefPubMedPubMedCentral Paschos KA, Majeed AW, Bird NC. Natural history of hepatic metastases from colorectal cancer—pathobiological pathways with clinical significance. World J Gastroenterol. 2014;20:3719–37.CrossRefPubMedPubMedCentral
12.
go back to reference Liaw CC, Chuang CK, Chang YH, Liao TY, Chang JW, Juan YH. Bladder urothelial carcinoma with peritoneal involvement: benefit of continuous maintenance chemotherapy. Anticancer Res. 2017;37:6443–51.PubMed Liaw CC, Chuang CK, Chang YH, Liao TY, Chang JW, Juan YH. Bladder urothelial carcinoma with peritoneal involvement: benefit of continuous maintenance chemotherapy. Anticancer Res. 2017;37:6443–51.PubMed
13.
go back to reference Laval G, Marcelin-Benazech B, Guirimand F, et al. French Society for Palliative Care; French Society for Digestive Surgery; French Society for Gastroenterology; French Association for Supportive Care in Oncology; French Society for Digestive Cancer Recommendations for bowel obstruction with peritoneal carcinomatosis. J Pain Symptom Manag. 2014;48:75–91.CrossRef Laval G, Marcelin-Benazech B, Guirimand F, et al. French Society for Palliative Care; French Society for Digestive Surgery; French Society for Gastroenterology; French Association for Supportive Care in Oncology; French Society for Digestive Cancer Recommendations for bowel obstruction with peritoneal carcinomatosis. J Pain Symptom Manag. 2014;48:75–91.CrossRef
14.
go back to reference Sakin YS, Kekilli M, Celebi G, Ozturk K, Uygun A, Bagci S. A rare case of upper gastrointestinal bleeding: duodenal metastasis of transitional cell carcinoma originating from Renal Pelvis. J Gastrointest Cancer. 2015;46:325–6.CrossRefPubMed Sakin YS, Kekilli M, Celebi G, Ozturk K, Uygun A, Bagci S. A rare case of upper gastrointestinal bleeding: duodenal metastasis of transitional cell carcinoma originating from Renal Pelvis. J Gastrointest Cancer. 2015;46:325–6.CrossRefPubMed
15.
go back to reference Antonini F, Rossetti P, Angelelli L, Macarri G. Life-threatening GI bleeding secondary to multiple gastric metastases from urothelial carcinoma of the renal pelvis. Gastrointest Endosc. 2018:87:1362–3. Antonini F, Rossetti P, Angelelli L, Macarri G. Life-threatening GI bleeding secondary to multiple gastric metastases from urothelial carcinoma of the renal pelvis. Gastrointest Endosc. 2018:87:1362–3.
16.
go back to reference Witowski J, Kawka E, Rudolf A, Jörres. A new developments in peritoneal fibroblast biology: implications for inflammation and fibrosis. Perit Dial Biomed Res Int. 2015;2015:134708. Witowski J, Kawka E, Rudolf A, Jörres. A new developments in peritoneal fibroblast biology: implications for inflammation and fibrosis. Perit Dial Biomed Res Int. 2015;2015:134708.
17.
go back to reference Flaberg E, Markasz L, Petranyi G, Stuber G, Dicso F, Alchihabi N, et al. High-throughput live-cell imaging reveals differential inhibition of tumor cell proliferation by human fibroblasts. Int J Cancer. 2011;128(12):2793–802.CrossRefPubMed Flaberg E, Markasz L, Petranyi G, Stuber G, Dicso F, Alchihabi N, et al. High-throughput live-cell imaging reveals differential inhibition of tumor cell proliferation by human fibroblasts. Int J Cancer. 2011;128(12):2793–802.CrossRefPubMed
18.
go back to reference Mukaida N, Sasaki S. Fibroblasts, an inconspicuous but essential player in colon cancer development and progression. World J Gastroenterol. 2016;22:5301–16.CrossRefPubMedPubMedCentral Mukaida N, Sasaki S. Fibroblasts, an inconspicuous but essential player in colon cancer development and progression. World J Gastroenterol. 2016;22:5301–16.CrossRefPubMedPubMedCentral
Metadata
Title
Pre-therapy CT scan showing peritoneal thickening from metastatic renal pelvis carcinoma patients
Authors
Tzu-Yao Liao
Chuang-Chi Liaw
Ke-Hung Tsui
Yu-Hsiang Juan
Publication date
01-10-2018
Publisher
Springer US
Published in
Medical Oncology / Issue 10/2018
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-018-1181-9

Other articles of this Issue 10/2018

Medical Oncology 10/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.